Publication | Closed Access

Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice

InflammationVascular DiseaseCardiovascular DiseaseIl-1 BetaImmunologyPathologyBiomarkersChronic InflammationInflammatory MarkerVascular BiologyApolipoprotein E-deficient MiceLipoprotein MetabolismMonoclonal AntibodiesMedicineAtherosclerosis